Pfitzer G, Zeugner C, Troschka M, Chalovich J M
II, Physiologisches Institut, Universität Heidelberg, Germany.
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5904-8. doi: 10.1073/pnas.90.13.5904.
Caldesmon is known to inhibit actin-activated myosin ATPase activity in solution, to inhibit force production when added to skeletal muscle fibers, and to alter actin movement in the in vitro cell motility assay. It is less clear that caldesmon can inhibit contraction in smooth muscle cells in which caldesmon is abundant. We now show that caldesmon and its 20-kDa actin-binding fragment are able to inhibit force in chemically skinned gizzard fiber bundles, which are activated by a constitutively active myosin light-chain kinase in the presence and absence of okadaic acid. This inhibitory effect is reversed by high concentrations of Ca2+ and calmodulin. Therefore, caldesmon may act by increasing the level of myosin phosphorylation required to obtain full activation. Our results also suggest that caldesmon does not act to maintain force in smooth muscle by cross-linking myosin with actin since competition of binding of caldesmon with myosin does not cause a reduction in tension.
已知钙调蛋白能在溶液中抑制肌动蛋白激活的肌球蛋白ATP酶活性,添加到骨骼肌纤维时能抑制力的产生,并能在体外细胞运动分析中改变肌动蛋白的运动。目前尚不清楚钙调蛋白是否能抑制富含钙调蛋白的平滑肌细胞的收缩。我们现在表明,钙调蛋白及其20 kDa的肌动蛋白结合片段能够抑制化学去表皮的砂囊纤维束中的力,在有无冈田酸的情况下,这些纤维束由组成型活性肌球蛋白轻链激酶激活。高浓度的Ca2+和钙调蛋白可逆转这种抑制作用。因此,钙调蛋白可能通过提高获得完全激活所需的肌球蛋白磷酸化水平来发挥作用。我们的结果还表明,钙调蛋白不会通过将肌球蛋白与肌动蛋白交联来维持平滑肌中的力,因为钙调蛋白与肌球蛋白结合的竞争不会导致张力降低。